Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000179179 | SCV000231385 | uncertain significance | not provided | 2017-04-12 | criteria provided, single submitter | clinical testing | |
Molecular Diagnostic Laboratory for Inherited Cardiovascular Disease, |
RCV000179179 | SCV001433372 | uncertain significance | not provided | 2019-03-15 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001852229 | SCV002276953 | uncertain significance | Duchenne muscular dystrophy | 2021-08-24 | criteria provided, single submitter | clinical testing | This sequence change replaces lysine with glutamic acid at codon 2792 of the DMD protein (p.Lys2792Glu). The lysine residue is highly conserved and there is a small physicochemical difference between lysine and glutamic acid. This variant is not present in population databases (ExAC no frequency). This variant has not been reported in the literature in individuals affected with DMD-related conditions. ClinVar contains an entry for this variant (Variation ID: 197991). Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be disruptive. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |